Profile data is unavailable for this security.
About the company
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. Combining image-guided local beta radiation and targeted drug delivery approaches, it is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Its lead radiotherapeutic candidate, REYOBIQ (rhenium (186Re) obisbemeda), is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers including primary and secondary liver cancers via intra-arterial injections.
- Revenue in USD (TTM)5.26m
- Net income in USD-20.58m
- Incorporated1997
- Employees21.00
- LocationPlus Therapeutics Inc4200 Marathon Blvd., Suite 200AUSTIN 78756United StatesUSA
- Phone+1 (858) 458-0900
- Fax+1 (302) 636-5454
- Websitehttp://www.plustherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theranexus SA | 0.00 | -2.94m | 31.87m | 10.00 | -- | -- | -- | -- | -0.3641 | -0.3641 | 0.00 | -0.1923 | 0.00 | -- | -- | 0.00 | -66.82 | -44.47 | -148.89 | -50.85 | -- | -- | -- | -- | -- | -37.71 | 2.90 | -- | -- | -- | 74.15 | -- | -56.53 | -- |
| Arecor Therapeutics PLC | 5.82m | -9.31m | 33.63m | 37.00 | -- | 10.25 | -- | 5.78 | -0.2208 | -0.2208 | 0.1368 | 0.0756 | 0.6482 | 18.58 | 1.93 | 136,783.80 | -103.79 | -53.69 | -187.88 | -68.26 | -2.45 | -- | -160.13 | -248.39 | 2.00 | -- | 0.0571 | -- | 10.50 | -- | -19.66 | -- | -- | -- |
| Zelluna ASA | 438.00 | -18.65m | 34.51m | 26.00 | -- | 4.86 | -- | 78,767.38 | -38.70 | -38.70 | 0.0004 | 3.08 | 0.00003 | -- | 0.001 | 416.67 | -144.37 | -36.03 | -159.75 | -39.51 | -- | -- | -4,257,300.00 | -- | -- | -- | 0.0162 | -- | -- | -- | -6.25 | -- | -37.05 | -- |
| Molecure SA | 1.22m | -5.80m | 34.53m | 71.00 | -- | 1.62 | -- | 28.41 | -1.20 | -1.20 | 0.2493 | 4.34 | 0.0553 | -- | 7.01 | 50,119.41 | -26.42 | -3.15 | -27.53 | -3.30 | 51.48 | 93.34 | -477.67 | -15.45 | -- | -- | 0.0588 | -- | -40.47 | 278.20 | -10.27 | -- | 12.49 | -- |
| Ascelia Pharma AB | 0.00 | -7.17m | 34.91m | 11.00 | -- | 3.76 | -- | -- | -0.693 | -0.693 | 0.00 | 0.7777 | 0.00 | -- | -- | -- | -60.31 | -54.24 | -85.44 | -64.44 | -- | -- | -- | -- | -- | -31.70 | 0.0097 | -- | -- | -- | 4.72 | -- | -32.17 | -- |
| ImmuPharma PLC | 0.00 | -4.52m | 36.69m | 6.00 | -- | 94.25 | -- | -- | -0.0089 | -0.0089 | 0.00 | 0.0007 | 0.00 | -- | -- | 0.00 | -139.44 | -89.81 | -259.88 | -121.17 | -- | -- | -- | -9,895.75 | -- | -2.76 | 0.00 | -- | -- | -- | 15.00 | -- | -56.60 | -- |
| Poolbeg Pharma PLC | 0.00 | -6.56m | 36.86m | 10.00 | -- | 2.69 | -- | -- | -0.0114 | -0.0114 | 0.00 | 0.0171 | 0.00 | -- | -- | 0.00 | -45.01 | -- | -46.84 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -47.29 | -- | -- | -- |
| Fermentalg SA | 12.78m | -11.54m | 36.88m | 63.00 | -- | 1.30 | -- | 2.89 | -0.1242 | -0.1242 | 0.1353 | 0.3156 | 0.2472 | 7.91 | 3.29 | 199,734.40 | -17.09 | -18.10 | -21.17 | -20.59 | 20.94 | 25.51 | -69.14 | -147.66 | 1.83 | -- | 0.2368 | -- | 183.32 | 43.52 | 8.99 | -- | -4.91 | -- |
| Medivir AB | 374.79k | -7.32m | 37.48m | 10.00 | -- | 1.52 | -- | 100.01 | -0.6789 | -0.6789 | 0.0348 | 0.5831 | 0.0238 | -- | 0.9374 | 398,400.00 | -46.44 | -31.75 | -69.67 | -38.14 | -- | -- | -1,953.24 | -740.12 | -- | -70.04 | 0.00 | -- | -54.36 | -16.77 | -38.06 | -- | -- | -- |
| Plus Therapeutics Inc | 8.92m | -23.08m | 40.21m | 21.00 | -- | 0.00 | -- | 4.51 | -2,773,103.00 | -2,773,103.00 | 892,051.60 | 1,920,005.00 | 0.2333 | 1.31 | 5.74 | 71,939.65 | -60.36 | -93.65 | -78.90 | -129.83 | 63.23 | 46.26 | -258.72 | -291.97 | 4.20 | -28.30 | 0.4628 | -- | -27.85 | 12.09 | -18.43 | -- | -19.87 | -- |
| Sequana Medical NV | 0.00 | -51.85m | 44.27m | 48.00 | -- | -- | -- | -- | -1.24 | -1.24 | 0.00 | -0.6848 | 0.00 | 1.61 | -- | 0.00 | -408.93 | -201.76 | -- | -- | -- | -427.70 | -- | -4,902.24 | 0.1559 | -0.5006 | 18.59 | -- | -85.19 | -35.84 | -37.13 | -- | -22.17 | -- |
| hVIVO PLC | 58.93m | 6.07m | 47.77m | 301.00 | 7.87 | 0.9527 | 4.64 | 0.8106 | 0.0077 | 0.0077 | 0.0748 | 0.0635 | 0.5914 | -- | 3.32 | 170,362.10 | 6.09 | 5.51 | 9.53 | 10.35 | -- | -- | 10.30 | 6.73 | 1.53 | -- | 0.2521 | 66.99 | 11.92 | 79.44 | -33.90 | -- | 154.59 | -- |
| Anatolia TaniveBytklj Unli Ar Ge SiveTiA | 12.09m | -5.86m | 48.29m | 247.00 | -- | 1.49 | -- | 3.99 | -1.38 | -1.38 | 2.85 | 7.63 | 0.3282 | 0.7324 | 4.92 | 2,815,434.00 | -15.90 | 5.77 | -17.08 | 6.10 | 63.69 | 80.17 | -48.44 | 15.31 | 2.09 | -- | 0.0869 | -- | 54.06 | 91.00 | -10.92 | -- | 96.35 | -- |
